MarketFriction

TAVEXIA LIFECARE LIMITED

BSE 539519 · Distributors
₹1.18 +1.72%
BSE close2026-10-01
Market cap₹44.5 Cr.

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales0.461.520.790.701.561.961.051.2216.845.698.500.64
Expenses0.030.930.330.210.640.900.270.4415.686.2315.030.88
Operating Profit0.430.590.460.490.921.060.780.781.16-0.54-6.53-0.24
OPM %93.48%38.82%58.23%70.00%58.97%54.08%74.29%63.93%6.89%-9.49%-76.82%-37.50%
Other Income0.000.000.000.100.040.000.260.000.040.005.850.12
Interest0.000.000.000.010.010.010.010.010.010.010.010.05
Depreciation0.090.080.180.100.100.090.120.080.130.160.180.14
Profit before tax0.340.510.280.480.850.960.910.691.06-0.71-0.87-0.31
Tax %20.59%25.49%75.00%27.08%27.06%27.08%7.69%5.80%25.47%-1.41%-18.39%-48.39%
Net Profit0.270.380.060.340.620.690.840.650.78-0.70-0.71-0.16
EPS in Rs0.000.000.000.000.000.010.010.020.02-0.01-0.01-0.00
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales0.431.291.542.213.555.2632.2331.67
Expenses0.360.631.441.141.581.9737.3037.82
Operating Profit0.070.660.101.071.973.29-5.07-6.15
OPM %16.28%51.16%6.49%48.42%55.49%62.55%-15.73%-19.42%
Other Income0.000.000.00-0.06-0.030.375.896.01
Interest0.060.050.020.030.020.050.100.08
Depreciation0.010.020.060.220.380.420.550.61
Profit before tax0.000.590.020.761.543.190.17-0.83
Tax %25.42%0.00%27.63%22.08%21.94%-23.53%
Net Profit0.000.440.020.551.192.490.21-0.79
EPS in Rs0.000.000.000.000.000.040.010.00
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%90%144%447%
Compounded Profit Growth%%%-103%
Stock Price CAGR%-16%4%42%
Return on Equity%5%5%-1%
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital3.203.208.0512.0519.2538.36
Reserves0.440.517.4310.144.714.87
Borrowings0.100.100.240.170.523.51
Other Liabilities0.510.640.640.922.1564.61
Total Liabilities4.254.4516.3623.2826.63111.35
Fixed Assets0.000.151.511.131.153.79
CWIP0.000.000.000.000.000.00
Investments0.000.038.1310.8910.8912.75
Other Assets4.254.276.7211.2614.5994.81
Total Assets4.254.4516.3623.2826.63111.35
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-0.59-0.92-1.47-2.770.11-14.34
Cash from Investing Activity-0.080.73-9.68-2.77-0.48-3.61
Cash from Financing Activity0.870.0311.165.510.3719.32
Net Cash Flow0.20-0.160.01-0.030.001.37
Free Cash Flow-0.67-1.14-3.05-2.77-0.37-17.53
CFO/OP-89%-920%-118%-123%25%282%
Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days384.81457.44498.78512.03385.12124.69
Inventory Days1,460.00542.942,578.551,034.762,403.9781.13
Days Payable538.81173.38412.10180.73528.62581.04
Cash Conversion Cycle1,306.00827.002,665.231,366.062,260.47-375.22
Working Capital Days449.88822.44959.571,039.48843.11284.71
ROCE %1.06%8.70%8.35%13.79%-0.11%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters4.01%4.01%3.11%3.11%3.11%3.63%3.62%3.62%6.40%6.40%6.39%6.39%
Public95.98%95.98%96.88%96.89%96.88%96.37%96.39%96.39%93.60%93.60%93.61%93.61%
No. of Shareholders4,6034,67311,0009,6668,73517,41729,25833,01735,98437,37536,62035,910

Fundamentals

Market Cap₹ 44.5 Cr.
Current Price₹ 1.16
Book Value₹ 1.13
ROCE-0.11 %
ROE-0.57 %
Dividend Yield0.00 %
Face Value₹ 1.00
Compounded Sales Growth (TTM)447%
Compounded Profit Growth (TTM)-103%
Consolidated figures.
Valuation
Market capRs 45 Cr
Enterprise valueRs 45 Cr
Price to book2.92x
Price to sales1.43x
EV / sales1.43x
Earnings yield-0.15%
P/E, 3-year average14.58x
P/B, 3-year average0.11x
Profitability
Operating margin (excl. other income)48.42%
Operating margin (incl. other income)45.70%
EBITDA margin-0.44%
Pre-tax margin-2.62%
Net profit margin-0.22%
Net margin, latest quarter-14.06%
ROE5.73%
ROCE8.09%
ROA5.29%
ROE, 3-year average6.12%
ROCE, 3-year average8.75%
ROA, 3-year average5.37%
ROIC (approx.)-3.47%
Tax rate27.63%
Other income / net worth-0.39%
Growth
Sales growth (latest year)43.51%
Profit growth (latest year)2650.00%
Sales CAGR, 3 years72.57%
Sales growth QoQ-92.47%
Sales growth YoY (latest quarter)-47.54%
Profit growth YoY (latest quarter)-113.85%
Per share
EPS (TTM)Rs -0.00
EPS (latest year)Rs 0.34
EPS (latest quarter)Rs -0.00
EPS, 3-year averageRs 0.19
Book value per shareRs 0.40
Sales per shareRs 0.83
Cash flow per shareRs -0.04
Free cash flow per shareRs -0.46
Efficiency
Asset turnover0.14x
Fixed asset turnover1.46x
Inventory turnover0.15x
Inventory days2422 days
Debtor days499 days
Debtors turnover0.73x
Creditor days581 days
Cash conversion cycle-375 days
Working capital days285 days
Leverage
Total debtRs 0 Cr
Cash and bankRs 0 Cr
Net debtRs 0 Cr
Debt to equity0.02x
Interest coverage-9.38x
Owners' fund to total sources94.62%
Debt to assets1.47%
Cash flow
Cash from Operating Activity (latest year)Rs -1 Cr
Cash from Investing Activity (latest year)Rs -10 Cr
Cash from Financing Activity (latest year)Rs 11 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs -18 Cr
FCFE (approx.: FCF + change in debt)Rs -17 Cr
Cash from ops / profit, 5 years-4.35x
Statement figures
Net sales (TTM)Rs 32 Cr
Net sales (latest year)Rs 2 Cr
Sales (latest quarter)Rs 1 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs -0 Cr
EBITDA (TTM)Rs -0 Cr
PBDT (TTM)Rs -0 Cr
Profit before tax (TTM)Rs -1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs -0 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs -0 Cr
Depreciation (TTM)Rs 1 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 1 Cr
Total income (latest year)Rs 2 Cr
Share capitalRs 8 Cr
ReservesRs 7 Cr
Shareholders' fundsRs 15 Cr
Total assetsRs 16 Cr
Net blockRs 2 Cr
InvestmentsRs 8 Cr
ReceivablesRs 3 Cr
InventoryRs 2 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)38.35
Ownership
Promoter holding6.39% (+2.77 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 2.92 is at the 14th percentile (median 7.55).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
Period539519Nifty 50Difference
1 week+0.0%-2.8% +2.8 pts
1 month+14.6%-6.8% +21.4 pts
3 months+57.3%-7.6% +65.0 pts
3 years+14.6%+14.2% +0.4 pts
5 years-59.2%+27.9% -87.1 pts

Red flags

F-score 4 of 8
explainWeak cash conversion Cash from operations was -295% of net profit over the last 3 years
explainHigh accruals Profit exceeded operating cash by 12% of total assets in 2026
lookInventory outrunning sales Inventory grew 84% vs sales +44% in 2026
lookShare dilution Share count up 113% in a year
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹1 Cr -47.5% vs Jun 2025. Net loss ₹0 Cr.

Activity

Compare
CompanyMcap (Cr)P/EROCE
M K Exim (India) Ltd26814.324.5 %
Ace Men Engg Works Ltd148928%
MRP Agro Ltd10518.1%
Kotia Enterprises Ltd187.444.20 %
Radhagobind Commercial Ltd3%
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of TAVEXIA LIFECARE LIMITED?

TAVEXIA LIFECARE LIMITED (539519) has a market capitalisation of Rs 44.5 Cr. at the 2026-10-01 close.

What were TAVEXIA LIFECARE LIMITED's latest quarterly results?

In the Jun 2026 quarter, TAVEXIA LIFECARE LIMITED sales was Rs 1 Cr (-47.5% vs Jun 2025) with a net loss of Rs 0 Cr.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03